Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-07

Clinical Trial Update: Biologics and Sublingual Immunotherapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on biologics and sublingual immunotherapy for allergic asthma conditions; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Biologics and Sublingual Immunotherapy

Snippet

Sponsor: Medical University of Silesia | Conditions: Asthma, Allergic | Phase 4 | Status: NOT_YET_RECRUITING